Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 21, 2017
Pharmacy Choice - News - Over-the-Counter Drugs - November 21, 2017

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 33     Next >>     Go To Page:

11/21/17 - A local look at kratom, the opioid-like botanical under fire from the FDA [The Frederick News-Post, Md.]
In Southeast Asia, the plant has been used for years as a substitute for opium, according to the National Center for Complementary and Integrative Health. The FDA, though, thinks differently. "Basically, what the agency is saying is that kratom behaves as an opioid and that it itself has troubling side effects," said Lyndsay Meyer, a spokeswoman f
11/21/17 - Phase 3 MURANO Study of Venetoclax Chosen as Late-Breaking Abstract at the 2017 American Society of Hematology Annual Meeting & Exposition, Highlighting AbbVie's Commitment to Helping Blood Cancer Patients
AbbVie, a global research and development-based biopharmaceutical company, today announced that the American Society of Hematology has accepted data from the Phase 3 MURANO study evaluating venetoclax tablets in combination with rituximab in patients with relapsed/refractory chronic lymphocytic leukemia, as an oral, late-breaking presentation...
11/20/17 - 'It never really leaves you.' Opioids haunt users' recovery
Addiction to powerful painkillers has ensnared millions of Americans, and created the worst drug epidemic in U.S. history. Now many share a daily struggle for recovery, a battle fraught with ironies, tragedies and sometimes shaky success. Survival means rejecting cravings for a high, often with the help of anti-addiction medicine similar to pills t
11/20/17 - Federal Register Extracts
SUMMARY: The Food and Drug Administration is announcing that it has received a petition requesting exemption from the premarket notification requirements for over-the-counter denture repair kits. FDA is publishing this notice to obtain comments in accordance with procedures established by the Food and Drug Administration Modernization Act of 1997.
11/20/17 - House Energy Committee Issues Hearing Memo on Modernizing FDA's Regs of OTC Drug
It will provide members an opportunity to better understand the current framework in place at the Food and Drug Administration for regulating over-the-counter drug products and to consider a bipartisan proposal to improve the OTC monograph process, one regulatory pathway used to bring such drugs to market. *Janet Woodcock, Director, Center for Drug
11/20/17 - Innovus Pharma Launches FlutiCare OTC Nasal Spray Allergy Relief in the U.S
Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men's and women's health and respiratory diseases, today announced that it has officially launched FlutiCare OTC in the U.S.. As a second phase of its launch,
11/20/17 - Innovus Pharmaceuticals Reports Nine Month Net Revenue of $6.4 million and Net Loss Decrease of 51.6% Compared to the Same Period in 2016
SAN DIEGO- Innovus Pharmaceuticals, Inc. today announced third quarter 2017 net revenue of $2.2 million compared to $1.9 million in net revenue for the same period in 2016.. This demonstrates our continued ability to generate significant sales growth from new and existing products through our Beyond Human Sales and Marketing Platform,' stated Bassa
11/20/17 - Innovus Pharmaceuticals Sponsors 10th Annual LD Micro Investor Conference to be Held on December 5, 2017
Innovus Pharmaceuticals, Inc., an emerging over-the-counter consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men s and women s health and vitality and respiratory diseases, today announced that i
11/20/17 - Innovus Pharmaceuticals Strengthens Its Intellectual Property Portfolio with New Patent for Its Sensum+ Product in Mexico
Innovus Pharmaceuticals, Inc., an emerging over-the-counter consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men's and women's health and vitality and respiratory diseases, today announced that it...
11/20/17 - Kmart Pharmacy Announces Copays as Low as $1* with Medicare Part D and Pharmacy Rewards
By a News Reporter-Staff News Editor at Managed Care Weekly Digest Medicare Part D members can now turn to Kmart Pharmacy as their 2018 preferred provider for pharmaceutical needs and receive substantial savings in their copays. That includes copays as low as $1 when they fill their prescriptions through a preferred network pharmacy such as Kmart
11/20/17 - Legal Cannabis Medical Market Shows Strong Growth
According to a report by Forbes, Brightfield Group, a cannabis market research firm indicates that the international market for cannabis is projected to hit $31.4 billion by 2021. Bethany Gomez, Director of Research for Brightfield Group, explained that the U.S. market is so much larger than the rest of the international markets combined.
11/20/17 - Medical Devices; Exemption From Premarket Notification: Over-the-Counter Denture Repair Kits
SUMMARY: The Food and Drug Administration is announcing that it has received a petition requesting exemption from the premarket notification requirements for over-the-counter denture repair kits. FDA is publishing this notice to obtain comments in accordance with procedures established by the Food and Drug Administration Modernization Act of 1997.
11/20/17 - Phase III IMpower150 Study Showed Genentech's TECENTRIQ (atezolizumab) and Avastin (bevacizumab) Plus Chemotherapy Significantly Reduced the Risk of Disease Worsening or Death in the Initial Treatment of People with a Type of Advanced Lung Cancer
Genentech, a member of the Roche Group, today announced that the Phase III IMpower150 study met its co-primary endpoint of progression-free survival and demonstrated that the combination of TECENTRIQ and Avastin plus chemotherapy provided a statistically significant and clinically meaningful reduction in the risk of disease worsening or death
11/20/17 - Therapeutic Advancements in Breakthrough Therapies for Treating Chronic Pain Take aim at Reducing Opioid use
Active in the markets today include: Veritas Pharma Inc., Perrigo Company plc. Cara Therapeutics, Inc., Trevena, Inc., Collegium Pharmaceutical, Inc. Veritas Pharma Inc. announces that its research arm, Cannevert Therapeutics Ltd. has signed a letter of intent with the Fundacin de Investigacin in San Juan, Puerto Rico, to conduct the first huma
11/18/17 - Isodiol International Acquires Global Rights to produce products under an Innovative Delivery System Patent [Sport360]
-Isodiol International Inc., a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, announced today that it has acquired international licensing rights for IsoDerm as well as five other proprietary pharmaceutical compounds to be delivered by the patented Direct Effects Technology, a.
11/17/17 - Improved NSAID Gels with 3x Faster Penetration Rates and 48 Hour Sustained Release Developed by Nemaura Pharma
By a News Reporter-Staff News Editor at Drug Week Sufferers of acute arthritic-related pain using' over the counter' gels to alleviate muscle ache and joint inflammation may be interested in the results of laboratory trials recently carried out by Nemaura Pharma. The UK- based company has developed two new gels which achieve up to three-times fas
11/17/17 - Isodiol International Acquires Global Rights to produce products under an Innovative Delivery System Patent
Isodiol International Inc., a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, announced today that it has acquired international licensing rights for IsoDerm? as well as five other proprietary pharmaceutical compounds to be delivered by the patented Direct Effects Technology
11/17/17 - NADDI Releases Third Quarter 2017 Statistics for NPLEx System
By a News Reporter-Staff News Editor at Health& Medicine Week The National Association of Drug Diversion Investigators- the nonprofit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers to prevent and investigate diversion of medicines for...
11/17/17 - Ultragenyx Announces Completion of Patient Dosing in First Cohort of Phase 1/2 Clinical Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency [Tehran Times (Iran)]
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that it has completed patient dosing in the first cohort of three patients enrolled in the Phase 1/ 2 study of DTX301, an adeno-associated virus gene therapy for the treatment of ornithine...
11/16/17 - Dauphin Clinic Pharmacy - Analyzes the Impact of Technology on Pharmacy Operations
DAUPHIN, MANITOBA, CANADA/ ACCESSWIRE/ November 16, 2017/ The Canadian pharmaceutical industry is the tenth largest in the world. For example, PricewaterhouseCoopers estimates that industry innovation in the United States will generate US $160 billion by 2025, including US $11 billion for data firms alone. Dauphin Clinic Pharmacy recognizes that ne
11/16/17 - Generic Drugs Stock Performance Review Catalyst Pharma, Flexion Therapeutics, Supernus Pharma and Allergan
If you want a Stock Review on CPRX, FLXN, SUPN, or AGN then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. DailyStockTracker.com shifts focus on Catalyst Pharmaceuticals Inc., Flexion Therapeutics Inc., Supernus Pharmaceuticals Inc., and Allergan PLC. The Generic Drugs market can be segmented into..
11/16/17 - Innovus Pharmaceuticals Strengthens Its Intellectual Property Portfolio with New Patent for Its Sensum+ Product in Mexico
Innovus Pharmaceuticals, Inc., an emerging over-the-counter consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men s and women s health and vitality and respiratory diseases, today announced that i
11/16/17 - Mitsubishi Tanabe Pharma America Announces 1,000 People with ALS Have Received FDA-Approved Treatment Option in First Three Months Available
Mitsubishi Tanabe Pharma America, Inc. today announced that more than 1,000 people with amyotrophic lateral sclerosis have been treated with RADICAVA since it became available in the U.S. in August as the first FDA- approved treatment option for the disease in more than 20 years. "After decades of waiting for a treatment option, the ALS commu
11/16/17 - RDD Pharma Raises $9.5M in Series B Funding to Fuel Global Development
NEW YORK and TEL AVIV, Israel, Nov. 16, 2017/ PRNewswire/ RDD Pharma, a leader in developing treatments for lower gastro-intestinal disorders, has raised $9.5 M in Series B funding, including $6 M from two new investors, Pharmascience, Inc. and an international life science fund, as well as existing investors OrbiMed and Capital Point. In paralle
11/16/17 - Sonoma Pharmaceuticals Announces FDA Approval of Expanded Indication for Alevicyn? to Add Antimicrobial Language
Sonoma Pharmaceuticals, Inc., a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced tissue care, today announced that the U.S. Food and Drug Administration has approved an expanded claim for the company s signature dermatology product, Alevicyn?
Articles(s): 1 - 25 of 33     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415